| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/30/2026 | ±2.5% | +1.8% | over-priced |
| 02/03/2026 | ±2.4% | +1.5% | over-priced |
| 11/03/2025 | ±2.3% | -3.0% | under-priced |
| 08/08/2025 | ±2.4% | -1.0% | over-priced |
| 05/05/2025 | ±2.6% | -0.5% | over-priced |
| 02/03/2025 | ±2.2% | +0.7% | over-priced |
| 10/30/2024 | ±1.2% | -0.2% | over-priced |
| 08/08/2024 | ±3.5% | +0.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.54 | $1.7B | $187M |
| Q2 FY2026 | $1.29 | $1.7B | $157M |
| Q1 FY2026 | $0.65 | $1.4B | $80M |
| Q4 FY2025 | — | $2.0B | $332M |
CLX (CLX) reports imminently, with the next report estimated for 10/27/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced CLX's earnings risk. Fundamentals into the print: EPS up 2.7% year-over-year, revenue up 0.1%. QuantLogix's live 5-factor engine currently reads CLX as a neutral at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →